These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8454112)

  • 1. The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy.
    O'Brien RC; Cooper ME; Jerums G; Doyle AE
    Diabetes; 1993 Apr; 42(4):604-9. PubMed ID: 8454112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
    Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive therapy in a model combining spontaneous hypertension with diabetes.
    Cooper ME; Rumble JR; Allen TJ; O'Brien RC; Jerums G; Doyle AE
    Kidney Int; 1992 Apr; 41(4):898-903. PubMed ID: 1513111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perindopril ameliorates glomerular and renal tubulointerstitial injury in the SHR/N-corpulent rat.
    Velasquez MT; Striffler JS; Abraham AA; Michaelis OE; Scalbert E; Thibault N
    Hypertension; 1997 Nov; 30(5):1232-7. PubMed ID: 9369281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy.
    Cooper ME; Allen TJ; O'Brien RC; Papazoglou D; Clarke BE; Jerums G; Doyle AE
    Diabetes; 1990 Dec; 39(12):1575-9. PubMed ID: 2245881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renoprotective differences between perindopril and enalapril in the diabetic hypertensive rat do not reflect glomerular angiotensin-converting enzyme activity.
    Duggan KA; Hodge G; Makarious MM; Charlesworth JA
    Clin Sci (Lond); 1998 May; 94(5):511-6. PubMed ID: 9682674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic renal microvascular disease: the role of hypertension and ACE inhibitors.
    Cooper ME; Rumble JR; Gin T; Lim-Joon T
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():23-7. PubMed ID: 1395113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of antihypertensive therapy.
    Fujihara CK; Padilha RM; Zatz R
    Diabetes; 1992 Mar; 41(3):286-93. PubMed ID: 1551488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of the angiotensin-converting enzyme inhibitor perindopril on diabetic glomerulopathy in streptozotocin-induced diabetic rats.
    Yan L; Yang R; Cheng H; Fu Z; Zhong G; Yan T
    Chin Med J (Engl); 1998 Apr; 111(4):306-8. PubMed ID: 10374392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
    Anderson S; Rennke HG; Brenner BM
    J Clin Invest; 1986 Jun; 77(6):1993-2000. PubMed ID: 3011863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat.
    Wilkinson-Berka JL; Gibbs NJ; Cooper ME; Skinner SL; Kelly DJ
    Nephrol Dial Transplant; 2001 Jul; 16(7):1343-9. PubMed ID: 11427623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative effects of perindopril and catechin on mesangial matrix and podocytes in the streptozotocin induced diabetic rats.
    Ertürküner SP; Başar M; Tunçdemir M; Seçkin İ
    Pharmacol Rep; 2014 Apr; 66(2):279-87. PubMed ID: 24911082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ACE inhibition on the expression of type IV collagen and laminin in renal glomeruli in experimental diabetes.
    Erensoy N; Yilmazer S; Oztürk M; Tunçdemir M; Uysal O; Hatemi H
    Acta Histochem; 2004; 106(4):279-87. PubMed ID: 15350810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats.
    Fabris B; Candido R; Armini L; Fischetti F; Calci M; Bardelli M; Fazio M; Campanacci L; Carretta R
    J Hypertens; 1999 Dec; 17(12 Pt 2):1925-31. PubMed ID: 10703891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function, glycemic control and perindopril in diabetic patients.
    Brichard S; Ketelslegers JM; Lambert AE
    Clin Exp Hypertens A; 1989; 11 Suppl 2():545-54. PubMed ID: 2691128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model.
    Raij L; Chiou XC; Owens R; Wrigley B
    Am J Med; 1985 Sep; 79(3C):37-41. PubMed ID: 2996345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short and long term effects of antihypertensive therapy in the diabetic rat.
    Anderson S; Rennke HG; Garcia DL; Brenner BM
    Kidney Int; 1989 Oct; 36(4):526-36. PubMed ID: 2681929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS-/- db/db mice.
    Zhang MZ; Wang S; Yang S; Yang H; Fan X; Takahashi T; Harris RC
    Am J Physiol Renal Physiol; 2012 Feb; 302(4):F433-8. PubMed ID: 22114203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.
    BMJ; 1991 Jan; 302(6770):210-6. PubMed ID: 1998761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension.
    Kelly DJ; Zhang Y; Hepper C; Gow RM; Jaworski K; Kemp BE; Wilkinson-Berka JL; Gilbert RE
    Diabetes; 2003 Feb; 52(2):512-8. PubMed ID: 12540629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.